Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
0.7610
-0.0405 (-5.05%)
At close: Oct 23, 2026, 4:00 PM EDT
0.7697
+0.0087 (1.14%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $137.05 million as of October 23, 2026. It is the 23,057th most valuable company in the world and the 3,865th biggest in the United States. Its market cap has decreased by 80.80% in one year.
Market Cap
137.05M
Enterprise Value
-33.20M
1-Year Change
-80.80%
Global Rank
Country Rank
#3,865 United States
Category
ChartMarket Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has decreased from $435.34M to $137.05M, a decrease of -68.52%. That is a compound annual growth rate of -18.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 137.05M | -85.65% |
| Dec 31, 2025 | 955.12M | 378.75% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veraxa Biotech AG | 141.41M |
| Atrium Therapeutics | 140.27M |
| Codexis | 140.17M |
| TuHURA Biosciences | 138.92M |
| Satellos Bioscience | 138.49M |
| Protara Therapeutics | 137.69M |
| Innate Pharma | 135.78M |
| Cue Biopharma | 135.55M |